Rich Pharmaceuticals, Inc. Increase (Decrease) in Notes Receivable, Current
Rich Pharmaceuticals, Inc. reported Increase (Decrease) in Notes Receivable, Current of $5.30 thousand for the 12-month period ending 2018-03-31, per its 10-K filed 2018-07-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesReceivableCurrent · last filed 2018-07-17
- Rich Pharmaceuticals, Inc. increase (decrease) in notes receivable, current for the quarter ending 2018-03-31 was $0.00.
- Rich Pharmaceuticals, Inc. increase (decrease) in notes receivable, current for the quarter ending 2017-12-31 was $0.00.
- Rich Pharmaceuticals, Inc. increase (decrease) in notes receivable, current for the quarter ending 2017-09-30 was $0.00.
- Rich Pharmaceuticals, Inc. increase (decrease) in notes receivable, current for the quarter ending 2017-06-30 was $5.30K.
- Rich Pharmaceuticals, Inc. increase (decrease) in notes receivable, current for fiscal 2018 was $5.30K, a 47.00% decline from fiscal 2017.
- Rich Pharmaceuticals, Inc. increase (decrease) in notes receivable, current for fiscal 2017 was $10.00K.
| Period end | Increase (Decrease) in Notes Receivable, Current 3 month | Increase (Decrease) in Notes Receivable, Current 6 month | Increase (Decrease) in Notes Receivable, Current 9 month | Increase (Decrease) in Notes Receivable, Current 12 month |
|---|---|---|---|---|
| 2018-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-17 | $0.00 derived: sum of 2 quarters · filed 2018-07-17 | $0.00 derived: sum of 3 quarters · filed 2018-07-17 | $5.30K 10-K · filed 2018-07-17 |
| 2017-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-20 | $0.00 derived: sum of 2 quarters · filed 2018-02-20 | $5.30K 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-29 | $5.30K 10-Q · filed 2017-12-29 | ||
| 2017-06-30 | $5.30K 10-Q · filed 2017-12-06 | |||
| 2017-03-31 | $10.00K 10-K · filed 2018-07-17 |